Anlon Healthcare acquires 56.67% equity shareholding in Bizotic Life Science
Consequent to this acquisition, the target company becomes a subsidiary of Anlon Healthcare
Anlon Healthcare has successfully completed the acquisition of 56.67% equity shareholding of Bizotic Life Science (target company) on March 20, 2026. Consequent to this acquisition, the target company becomes a subsidiary of Anlon Healthcare.
Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in ndia and international markets.
